These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39133883)

  • 1. Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers.
    Coarelli G; Dubec-Fleury C; Petit E; Sayah S; Fischer C; Nassisi M; Gatignol P; Dorgham K; Daghsen L; Daye P; Cunha P; Kacher R; Hilab R; Hurmic H; Lamazière A; Lamy JC; Welter ML; Chupin M; Mangin JF; Lane R; Gaymard B; Pouget P; Audo I; Brice A; Tezenas du Montcel S; Durr A
    Neurology; 2024 Sep; 103(5):e209749. PubMed ID: 39133883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
    Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
    Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.
    Nassisi M; Coarelli G; Blanchard B; Dubec-Fleury C; Drine K; Kitic N; Sancho S; Hilab R; Tezenas du Montcel S; Junge C; Lane R; Arnold HM; Durr A; Audo I
    JAMA Ophthalmol; 2024 Apr; 142(4):301-308. PubMed ID: 38421662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
    Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
    Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
    Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
    Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
    Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G
    Mov Disord; 2024 May; 39(5):788-797. PubMed ID: 38419144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Analysis of the Relation Between Clinical Impairment and Gray Matter Degeneration in Spinocerebellar Ataxia Type 7 Patients.
    Contreras A; Ramirez-Garcia G; Chirino A; Morgado-Valle C; Pasaye EH; Hernandez-Castillo C; Díaz R; Fernandez-Ruiz J; Beltran-Parrazal L
    Cerebellum; 2021 Jun; 20(3):346-360. PubMed ID: 33184781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
    Rezende TJR; Adanyaguh I; Barsottini OGP; Bender B; Cendes F; Coutinho L; Deistung A; Dogan I; Durr A; Fernandez-Ruiz J; Göricke SL; Grisoli M; Hernandez-Castillo CR; Lenglet C; Mariotti C; Martinez ARM; Massuyama BK; Mochel F; Nanetti L; Nigri A; Ono SE; Öz G; Pedroso JL; Reetz K; Synofzik M; Teive H; Thomopoulos SI; Thompson PM; Timmann D; van de Warrenburg BPC; van Gaalen J; França MC; Harding IH
    J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):682-690. PubMed ID: 38383154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
    de Oliveira CM; Leotti VB; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Saraiva-Pereira ML; Jardim LB
    Mov Disord; 2023 Jan; 38(1):26-34. PubMed ID: 36129443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six Months in Early Spinocerebellar Ataxia.
    Rezende TJR; Petit E; Park YW; Tezenas du Montcel S; Joers JM; DuBois JM; Moore Arnold H; Povazan M; Banan G; Valabregue R; Ehses P; Faber J; Coupé P; Onyike CU; Barker PB; Schmahmann JD; Ratai EM; Subramony SH; Mareci TH; Bushara KO; Paulson H; Klockgether T; Durr A; Ashizawa T; Lenglet C; Öz G;
    Mov Disord; 2024 Oct; 39(10):1856-1867. PubMed ID: 39056163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
    Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G
    Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.
    Rodríguez-Labrada R; Martins AC; Magaña JJ; Vazquez-Mojena Y; Medrano-Montero J; Fernandez-Ruíz J; Cisneros B; Teive H; McFarland KN; Saraiva-Pereira ML; Cerecedo-Zapata CM; Gomez CM; Ashizawa T; Velázquez-Pérez L; Jardim LB;
    Cerebellum; 2020 Jun; 19(3):446-458. PubMed ID: 32086717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking longitudinal thalamic volume changes during early stages of SCA1 and SCA2.
    Grisoli M; Nigri A; Medina Carrion JP; Palermo S; Demichelis G; Giacosa C; Mongelli A; Fichera M; Nanetti L; Mariotti C
    Radiol Med; 2024 Aug; 129(8):1215-1223. PubMed ID: 38954239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3.
    Faber J; Schaprian T; Berkan K; Reetz K; França MC; de Rezende TJR; Hong J; Liao W; van de Warrenburg B; van Gaalen J; Durr A; Mochel F; Giunti P; Garcia-Moreno H; Schoels L; Hengel H; Synofzik M; Bender B; Oz G; Joers J; de Vries JJ; Kang JS; Timmann-Braun D; Jacobi H; Infante J; Joules R; Romanzetti S; Diedrichsen J; Schmid M; Wolz R; Klockgether T
    Mov Disord; 2021 Oct; 36(10):2273-2281. PubMed ID: 33951232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.